Registered as of 10/9/2014
2020 Management Eric Weinberg
20/10 Perfect Vision
Frieder Loesel, Managing Director
5AM Ventures
Hannah H. Chang, Associate
Abbott Laboratories
John Capek, Executive Vice President, Medical Devices
Abbott Medical Optics
Leonard Borrmann, Divisional Vice President, R&D
Darren Inouye, Commercial Director Refractive & Global Marketing Steve Jwanouskos, Associate Director, Regulatory Affairs
Ken Kadziauskas, Associate Director & Marketing, Global Upstream Terry Koritz, Divisional Vice President, Commercial Refractive
Catherine Mazzacco, Divisional Vice President, Commercial Operations Jane Rady, Divisional VP, Business Development
MK Raheja, PhD, MBA, Global Head, Cataract R&D
Cameron Rouns, Divisional Vice President, Global Strategic Marketing Murthy V. Simhambhatla, PhD, President
David Tanzer, MD, Chief Medical Officer, DVP Medical Affairs Troy Wu, MD, Director, Business Development
AbbVie
Deb van Riet, Director
Samir Tari, Clinical Development
Accutome
Joelle Vega, President Ace Vision Group
Dr. AnnMarie Hipsley, Founder
Acucela
Hien DeYoung, VP, Human Resources Karin Ludwig, MD, VP, Clinical Development
AcuFocus
Wellentina Greer, Director, Global Strategic Marketing Matt Larson, Commercial Director, Asia Pacific
Jim Mazzo, Chairman & CEO
Yari Mitchell, Director, Global Medical Education & Professional Relations Nick Tarantino, Chief Clinical & Regulatory Officer
AECOS
Trudy Larkins, Executive Director
Aerie Pharmaceuticals Vicente Anido, CEO
Casey Kopczynski, Chief Scientific Officer Brian Levy, Chief Medical Officer
Tom Mitro, President & Chief Operating Officer Richard Rubino, Chief Financial Officer
Craig Skenes, Vice President, Business Development
Aerpio Therapeutics
Joseph H. Gardner, PhD, President & CEO
AGTC
Jeff Chulay, Vice President & CMO Dan Menichella, CBO
Susan Washer, President & CEO
Akorn
Adrienne Graves, Former President & CEO
Al Consultants
Avner Ingerman, Owner
Alcon
Judith Anderle, Global Product Director, Ocular Allergy Laurent Attias, Head, Global Commercial Strategy Sandipan Bagchi, Global Marketing Manager Sharon Bakalash, MD, PhD, Technical Lead Cataract
David Chacko, Strategic Assistant to the Global Head of Alcon Fred Ellis, Head, Professional Affairs, US Pharmaceuticals
Robert Fisher, Global Pharma Market Access Director Heather Floyd, PhD, Technical Lead Pharmaceutical Jeff George, Global Head
Paul Hallen, Global Franchise Director-Vitreoretinal Oliver Kersting, General Manager
Gregory Kunst, Global Marketing Director, Retina Pharmaceuticals Sabri Markabi, MD, CMO & Head R&D
Anmol Mullins, Director, Global Market Access Jim Murphy, VP & GM, US Vision Care
David Nieto, Chief Financial Officer
Aaron Osborne, Head, GMA Pharma Franchise Scott Pennington, Head, R&D Alliances
Dr. Cadmus Rich, Therapeutic Unit Head, IOLs Lukas Scheibler, PhD, VP, Ideation Center
Gregg Stanhope, Director, Professional Affairs, US Pharmaceuticals Catherine Truitt, PhD, Technical Lead, VGR
Robert Warner, Area President, United States & Canada
Alexion Pharmaceuticals Bill Lundberg, Vice President
Alimera Sciences
Rick Eiswirth, Chief Operating Officer & Chief Financial Officer C. Daniel Myers, President & Chief Executive Officer
Alkeus Pharmaceuticals Leonide Saad, President & CEO
Allegro Ophthalmics
Hampar Karageozian, Co-Founder & CEO
Vicken Karageozian, MD, Co-Founder & Chief Technology Officer
Allergan
Yehia Hashad, VP, Global TA Head, Retina
Patrick Johnson, Sr. Director, Business Development David Pyott, Chairman of the Board and CEO
Brian Strem, Director, Business Development
Ramin Valian, VP, Global Strategic Marketing, Eye Care
Scott Whitcup, MD, Executive Vice President, Head of R&D & Chief Scientific Officer
Allysta Pharmaceuticals Benson Fong, CBO Henry Hsu, CEO
Altacor
Dr. Francesca Crawford, CEO
Amakem
Jack Elands, CEO
Steve Pakola, Chief Medical Officer
Kieran Rooney, VP, Business Development
American Academy of Ophthalmology Jane Aguirre, Vice President, Global Alliances David W. Parke, MD, CEO
Richard Zorab, Vice President, Clinical Education
AmorChem
John Clement, General Partner
Apellis Pharmaceuticals
Cedric Francois, CEO & President
Federico Grossi, VP of Clinical Development David Watson, Executive VP of Development
Apex Eye
Robert Benza, MD, PI
Ed Meier, MD, Director of Clinical Research
Wendy Shoger, Director, Clinical Research Development
Appletree CI Group AG Todd Galles
Georg Mathis, Physician
AppMedicine Robby Huang, CEO
Aquesys
Ron Bache, CEO
ASCRS
Don Bell, COO
Eric Donnenfeld, MD, President David Karcher, Executive Director
ASCRS Media
Jeff Brownstein, Director of Sales Donald Long, Director of Media
Cathy Stern, Production Manager Paul Zelin, Sales Representative
ASSORT
Noel Alpins, CEO
Doug Mastel, Product Specialist
Avalanche Biotechnologies Linda Bain, Chief Financial Officer Samuel Barone, Chief Medical Officer Thomas W. Chalberg, PhD, Founder & CEO Hans Hull, SVO Business Operations
Avedro
Steve Blinn, Chief Commercial Officer
Avelino Lab USA Scott Korney, COO
Gene Lee, Chairman & CEO
Weston Nichols, Director, Sales & Marketing
Avella
Leslie Yendro, VP, Business Development
BAM Ophthalmology Consultants Beth Marsh, Principal
Barclays
Priya Karani, Director Jonathan Piazza, Director
Bascom Palmer Eye Institute
William Culbertson, Professor of Ophthalmology Philip Rosenfeld, MD, Professor of Ophthalmology
Bausch + Lomb
Chuck Hess, Sr. Director of Marketing
Raymond Larwood, Vice President Pharmaceutical Sales Sanjay Malieckal, Director, Marketing
Quintus Ngumah, Director Clinical Development & Medical Strategy Calvin W. Roberts, MD, Executive Vice President & Chief Medical Officer Tracy Valorie, Vice President, Pharma Marketing
Jon Williams, Director, Medical Affairs
Bay Area Retina
Roger Goldberg, Physician
Bayer Healthcare
Robert Lieberman, Associate Director, Global Market Research
Bayer HealthCare Pharmaceuticals
Tom Cordaro, Director, Strategy & Portfolio Management Ken Shaw, PhD, Sr. Director, BD&L & SM
Baylor College of Medicine
Jack Holladay, MD, Clinical Professor of Ophthalmology
Beaver Visitec International
Peter Hemingway, V.P. Strategy & Business Development
BioComm Network
Tad Heitmann, MBA, President
Biolight
Suzana Nahum Zilberberg, CEO
BioQuest
Roger Anderson, Partner
Karen Bertrand, SVP, Biopharmaceutical Practice Leader
Biosyntrx
Ellen Troyer, CEO & Chief Research Officer
BJL Medical
Barry J Linder, MD, MS, President
Brar-Parekh Eye Associates Jai Parekh, MD, Managing Partner
Bryn Mawr Communications
David Cox, President & Group Publisher Steve Daily, News Director
Alan Guralnick, Group Publisher
Bucci Laser Vision Institute
Frank A. Bucci, President & Founder Bullseye Dropper
Robert Behan, Director
C.C.G. Partners
Rick Coulon, Managing Partner
California Pacific Medical Center
Rona Silkiss, Chief, Div. of Ophthalmic Plastic, Reconstructive & Orbital Surgery
Calpain Therapeutics Tim Lovell, CEO
Cantor Fitzgerald
Caroline Corner, Research Analyst
Carle
Michael Tsipursky, Physician
Carl Zeiss Meditec
Scott Meyer, Director, Strategic Business Development Angelo Rago, SVP, Innovation & Operations
Cativer Bio Insights Stephen Judd, President
Center for Excellence in Eye Care William Trattler, Director of Cornea
Charles Retina Institute Steve Charles, Founder & CEO
CHU Gabriel Montpied
Dr. Hayette Rebika, Ophthalmologist
Cincinnati Eye Institute
Edward J. Holland, MD, Director, Cornea Services
Clarion Healthcare
Carol Kearney, Managing Director
Clarity Medical Systems Barry J. Linder, MD, MS, CMO Rick Mangum, CFO
Mark Mellin, CEO
Clarus Ventures
Emmett Cunningham, Jr., MD, PhD, MPH, Partner Nick Galakatos, Managing Director
Michele Park, Principal
Kurt Wheeler, Managing Director
ClarVista Medical
Glenn Sussman, VP, R&D
ClinOps International
Yordak Salermo, Clinical Consultant
ClinReg Consulting Services Judy Gordon, President
Lee Kramm, MD, Senior Regulatory Consultant Roger Meyer, MD, Consultant
Cockrell Interests Bobby Hatcher, CEO
Cole Eye Institue
Neema G. Mayhugh, Director of Commercial Affairs
Columbia University Medical Center
Stephen Trokel, Vice Chair, Department of Ophthalmology
Cornea/Retinal Diseases Image Analysis Reading Centers Beth Ann Benetz, Director
Cressey & Company
Steve Dildine, Vice President
D.O.R.C. International
Pieter Karels, Strategic Product Development Director Willem Rosenquist, Strategic Product Management Director
Dean McGee Eye Institute Gregory Skuta, President & CEO
Department of Ophthalmology & Vision Sciences, UC Davis Christopher Murphy, Professor of Comparative Ophthalmology Destum Partners
Matt Vanderberg, Managing Director, Partner
DigiSight Technologies Doug Foster, CEO
Draper Laboratory
Brian Daniels, Program Manager
Durrie Vision
Daniel Durrie, MD, Founder & President
EagleVision
Murray Beard, President
Eleven Biotherapeutics Abbie Celniker, CEO
Michael Goldstein, MD, MBA, Vice President of Clinical Research Greg Perry, CFO
Gary Sternberg, Executive Vice President of Corporate & Business Development Karen Tubridy, Chief Development Officer
Encompass Pharmaceutical Services Thomas Rowe, President
Encore Vision
Bill Burns, President & CEO
Envisia Therapeutics Neal Fowler, CEO
Tomas Navratil, Vice President, Development
Ash Nijhawan, Vice President, Business Development Ben Yerxa, CSO
Ethis Communications David Kellner, Exectuvie VP
Lavon Kellner, Principal Director of Sales Luca Sergio, CEO
Eton Park Capital Matt Reischl, Analyst
EuroTimes
Howard Larkin, Contributing Editor ExSight Capital
James Murray, Partner
Eye Consultants of Texas Phillips Labor, Physician
Eye Surgeons Associates Lisa Arbisser, Physician
Eye Therapies Tony Moses, CEO
EyeGate Pharma Stephen From, CEO
Michael Manzo, VP of Engineering
EyeKor
Ron Danis, Managing Partner, CSO
EyeNet Magazine
Patty Ames, Executive Editor Peggy Denny, Senior Editor Chris McDonagh, Senior Editor
Edna Shaw, Contributing Writer & Editor
EyeQ Research
Michael Lachman, Founder
EyeSonix
Don Schwartz, President
EyeWorld
Erin Boyle, Editor
Julio Guerrero, Video Editor Lauren Lipuma, Staff Writer Ellen Stodola, Staff Writer
FDA
Kesia Alexander, Deputy Director
Wiley A. Chambers, MD, Supervisory Medical Officer, Division of Transplant & Ophthalmology Products Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation
Eva Rorer, Medical Officer
Michelle Tarver, MD, Medical Officer Federal University of Sao Paulo
Rubens Belfort, Head Professor
Cristina Muccioli, MD, Professor of Ophthalmology
FishmanVision
Harvey Fishman, Medical Director
Foresite Capital Stella Sarraf, Advisor
ForSight Labs
Eugene de Juan, MD, Founder & Vice Chairman Angela Macfarlane, President & CEO
ForSight Vision4
Signe Erickson, VP, Development & Clinical
ForSight VISION5
Charles Semba MD, Chief Medical Officer John Maroney, President & CEO
Anne Rubin, Vice President, Marketing
Foundation Fighting Blindness
Tom Capetan, Business Development Consultant Patricia Zilliox, Chief Drug Development Officer
Genentech Eugene An, GPM
Warner Biddle, Vice President Lucentis Ophthalmology Sales & Marketing Ann Clark, Senior Medical Science Liaison
Atul Dandekar, Lifecycle Leader
Caroline Hartford, Senior Product Manager Thomas Kochy, Director, Pipeline Strategy Chad McCrea, SPM
Ajay Narasimha, Senior manager
Elisabeth Warren, Associate Director, Pipeline Strategy Thomas Zioncheck, Senior Director, Business Development
Glaucoma Research Foundation Tom Brunner, President & CEO
GlaxoSmithKline
Claudine Bruck, VP & Head Ophthalmology R&D Rabia Ozden, MD, Head, Clinical Ophthalmology R&D
Google X
Brian P. Otis, PhD, Founder, Smart Contact Lens Project
GrayBug
Michael O'Rourke, CEO
Gray Communications Michele Gray, Principal
Gurnet Point Capital Todd Holmes, Director Anne Rogove, Analyst
Gustavson Development Michael Gustavson, President
GZ Paul Management Services Helmut A. Krueger, Director
Harvard Medical School
Jonathan H. Talamo, MD, Associate Professor of Ophthalmology
Healios
Al Reaves, Director & Chief Development Officer
HealthCare Royalty Partners Matt Reber, Managing Director
HealthCor Partners Ed Ross, Analyst
Healthios Capital Markets Greg Shearer, Managing Director
Hospital das Clinicas
Mauro Goldbaum, Ophthalmologist
Hoya Corporation
Takashi Iizuka, Manager, Business Development
i-Optics
Jeroen Cammeraat, CEO
Wayne Caulder, Cassini VP North America David Friess, Clinical Consultant
Icare Finland
Ari Kukkonen, R&D Director
iCo Therapeutics
Dr. Peter Hnik, Chief Medical Officer
Susan Koppy, Corporate Business Development Executive Andrew Rae, CEO
Icon Bioscience
Hector Casab, VP Finance
Iconic Therapeutics Bill Greene, CEO
Tanya Shnaydman, Director, Corporate Development & Operations
IDDI
Linda Danielson, COO
Stan Wysocki, Senior Director, Business Development & Sales Operations
Illinois Eye & Ear Infirmary
Ahmad A. Aref, MD, Assistant Professor of Ophthalmology
Illinois Institute of Technology
Jennifer Kang-Mieler, Associate Professor of Biomedical Engineering
Imex Clinic SL
Jose Maria Gimeno Reiz, President & CEO
Implandata Ophthalmic Products GmbH Max G. Ostermeier, CEO & President
Indiana University
Alon Harris, MS, PhD, FARVO, Director, Clinical Research
Infinite Vision Optics Carsten Laue, CEO
Infinov
Benoit Collet, President
InnFocus
Russ Trenary, President & CEO
Guy Van de Weyer, Director Operations Europe, Middle East, Africa
Integrity Digital Solutions Chris Moore, CEO
InterWest Partners
Charline Gauthier, Executive-in-Residence Gilbert H. Kliman, MD, Managing Director Reza Zadno, Venture Partner
Intralase
Ronald Kurtz, CEO
IOPtima
Ronen Castro, CEO
Iris Advanced Eye Centre Raman Bedi, MD, Physician
Iris Pharma
Pierre-Paul Elena, CEO
Yann Quentric, Head of Business Development & Marketing
ISOPT
Dr. Sara Krupsky, Chairperson
iSTAR Medical Pierre Geens Michel Vanbrabant
Ivantis
Dave Van Meter, CEO
J.P. Morgan
Michael Gaito, Managing Director & Head of West Coast Life Sciences
Jeffrey Hoffman, Managing Director, Head West Coast Healthcare Investment Banking
Janssen Pharmaceuticals
Susan Orr, Global Medical Affairs Leader, Ophthalmology
Janssen Research & Development
Rob Willenbucher, Head Cell Therapy & Janssen Incubators Japan Focus
Makoto Wakayama, Assistant Manager
JFC Sales Plan
Masataka Fujikawa, Chief Tsugitomo Takimoto, Chairman
John Guckes & Associates John Guckes, President
Johnson & Johnson Ellie Chabi, MD, Physician Hassan Chaouk, X
Christine Knoblauch, Vice President, WW Business Development Ashley McEvoy, Company Group Chairman
Brian Schwam, Chief Medical Officer
Art Shedden, MD, MBA, Senior Director, Global Medical Affairs
JP Morgan
Jeffrey Hoffman, Managing Dir. & Head West Coast Healthcare Investment Banking
Jump Capital
Garrett Vygantas, MD, Partner
JunoPacific
Kern Bhugra, President
Kala Pharmaceuticals
Kim Brazzell, Chief Medical Officer
Charlie McDermott, Chief Business Officer
Kato Pharmaceuticals Terry McGovern, CEO
Kepler
Schalon Newton, Principal
Kraff Eye Institute
Colman R. Kraff, MD, Director of Refractive Services
Laboratories Thea
Francou Colin, Corporate Business Development Manager Pascale Pouliquen, Corporate Medical Director
Laboratories SALVAT Hugo Peris, Board Member
LacriPen. (LacriSciences, LLC)
Paul Gavaris, M.D., Managing Member
LayerBio
Ken Mandell, CEO
Leerink Partners
Tony Gibney, Managing Director Joseph Schwartz, Managing Director
Leica Microsystems AG
Heinrich Dreyer, Vice President, Medical Division
LensGen
Michael Colaco, Board Member Shivbir Grewal, Board Member
Michael Landreville, Chief Operating Officer Ram Rao, CEO
Lenticular Research Group George McArdle, Optometrist
Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP
Linden Capital Partners Tony Davis, Managing Partner Eric Larson, Managing Partner
Link Consulting
Marsha Link, PhD, Principal
Longitude Capital
Juliet Bakker, Managing Director
Lumoptik Eye
Thomas Janicki, President
Lutronic
Haelyung Hwang, President Jongmin Kim, CTO
M&S Technologies
Joseph Marino, President & CEO
Mark Packer MD Consulting Mark Packer, President
Market Scope Bill Freeman
Massachusetts Eye & Ear
Bonnie M. Brodowski, MBA, Program & Business Development Manager Reza Dana, MD, MPH, MSc, Claes H. Dohlman Professor of Ophthalmology Ojas Mehta, Director, IP & Commercial Ventures
Jonathan Talamo, Site Director
Mati Therapeutics Bob Butchofsky, CEO Chris Muller, CCO
MC2 Biotek
Frederic Gomez, Advisor, Business Development Jesper J. Lange, President
Morten Prostegaard, VP Operations
McMaster University
Zuhal Butuner, Associate Professor
medeuronet
Kristine Morrill, Managing Director
Medical Device Daily Larry Haimovitch, Reporter
Medicem
Eugen Chicevic, Managing Director Giacomo Nizi
Vladimir Stoy, President
Mediphacos Ophthalmic Professionals Gustavo Couri, Commercial Director Marcelo Soares, President
Mercy Eye Clinic
Jack Bussa, MD, Physician
Mid Atlantic Bio Angels Eric D. Kanter, MD, Partner
Mid Atlantic Retina-Wills Eye Institute Carl Regillo, MD, Professor of Ophthalmology
Minnesota Eye Consultants
Richard Lindstrom, MD, Founder & Attending Surgeon
Mobius Therapeutics Ed Timm, President & CEO
Monash Vision Group
Jeanette Pritchard, General Manager
Moorfields Pharmaceuticals
Rob Wallace, Business Development Director
Mynosys Cellular Devices
John N. Hendrick, President & CEO
Mystic Pharmaceuticals
Timothy Sullivan, President & CEO
National Eye Institute, NIH
Matthew J. McMahon, PhD, Director, Office of Translation Research
Neurotech
Quinton Oswald, CEO Rhett Schiffman, VP & CMO Rich Small, CFO
NeuroVision
Steven Verdooner, CEO
New World Medical
Suhail Abdullah, Director, Research & Development Bilal Khan, Vice President & Chief Operating Officer
NextGen Healthcare
Tera Roy, Specialty Director, Ophthalmology Nicox
Mike Bergamini, EVP & Chief Scientific Officer
Gavin Spencer, EVP, Corporate Development
NIDEK
Tokio Ueno, Senior Manager
Nightstarx Aniz Girach, CMO
nJoy Vision
Dawn Holsted, President & CEO
North Shore LIJ Health System Ira Udell, Physician, Chairman
NotalVision Yair Alster, CMO Barak Azmon, CEO Scott Jones, President
Novaliq GmbH
Gerald Cagle, MD, Physician Bernhard Guenther, CEO
Frank Loescher, Director, Business Development Tony Pettigrew, Director, New Products
Dieter Scherer, CSO
Hartmut Voss, Executive Advisor
Novartis Pharma Ronny Hashmonay
Dirk Sauer, Global Head, Development Franchise Ophthalmics Mark Wuttke, Global Brand Manager, New Products, Medical Retina Edward Wright, BD&L Manager
Novozymes Biopharma
Michael Foldager, Global Marketing Manager
NSBRI
Dorit Donoviel, PhD, Deputy Chief Scientist and Industry Forum Lead
Ocugen
Charlie Kang, CEO Ocular Instruments
Scott Corning, VP, Sales & Marketing
Phil Erickson, President
Raymond Graham, Director of Engineering & Product Development Amar Sawhney, PhD, President & CEO
Brad Smith, CFO
Oculeve
Michael Ackermann, President & CEO
OCULUS Surgical
Ron Gilliland, President and CEO
Bob Zatarain, V.P. Business Development
OD-OS
Dr. Winfried Teiwes, CEO
Oftalmedica
Benedetto Sgroi, CEO
OHR Pharmaceutical
Irach Taraporewala, CEO & President
ONL Therapeutics John Freshley, CEO
David Zacks MD, PhD, Co-Founder and CSO
Oligasis
Victor Perlroth, Founder & CEO
Opthalmiatreion Athens Eye Hospital Iordanis Chatziangeldis, Ophthalmologist
Ophthalmology Times Mark Dlugoss, Editor-in-Chief
Ophthotech Mike Atieh
Richard Beckman, Senior Vice President
Hans Christinger, VP, Business Development & Alliance Management Kathy Galante, Vice President, Investor Relations
David R. Guyer, MD, CEO
Jeffrey Nau, VP, Clinical & Medical Affairs Samir Patel, President
Michael Rafa, VP & Chief Patent Counsel
Keith Westby, Sr. Vice President, Program Management & Business Operations
Barbara Wood, SVP, General Counsel & Corporate Secretary
Oppenheimer & Co
Yigal Nochomovitz, Analyst, Equity Research
OptiMedica
Mark Forchette, Former CEO
Ora
Stuart Abelson, President & CEO
Ryan Bouchard, Director, Medical Devices
Matthew Chapin, Sr. VP, Corporate Development Phil Gioia, Corporate Development
Mashfiq Haque, Director, Business Development Eliot Lazar, Physician
Hiro Matsuda, General Manager
Joshua Moriarty, Director, Medical Communications George Ousler, Vice President, Dry Eye
MaryJane Rafii, Director, Business Development Van Sandwick, Corporate Development Associate Aron Shapiro, Vice President
Oraya Therapeutics
Jim Taylor, President & CEO
Pacific Eye & Laser Institute
Rochelle Rongavilla, Research Supervisor Jimmy Tan, Managing Director
Palo Alto Investors John Doux, Physician
Pamel Vision & Laser Group Gregory Pamel, Owner
Panoptes
Franz Obermayr, CEO
PanOptica
David P. Bingaman PhD, DVM, ACVO, Sr. Director & Head, Retina Development Paul Chaney, President & CEO
Marty Wax, MD, Chief Medical Officer & EVP, R&D Paragon BioTeck
Patrick Witham, CEO
Parion Sciences
Jose Boyer, VP Research & Ophthalmology Development
Patterson Thuente IP
Paul Onderick, Intellectual Property Attorney & Eye Doctor
PentaVision
Rich Kirkner, Executive Editor
Andrew Mathis, Managing Editor of Retinal Physician
Pharmacos
Jim Currie, Principal
PharmaQuest Associates Lisa Grillone, President
Phillips Medisize
Vince Hull, Director, Product Development Joe Slade, Program Manager
Piper Jaffray & Co.
J.P. Peltier, Managing Director and Global Group Head of Healthcare Investment Banking
PowerVision
Barry Cheskin, President, CEO & Co-Founder Matt Frinzi, Chief Business Officer & Founder
PRECEYES Gerrit Naus, CEO Atul Sinha
Presbia
Vlad Feingold, Executive VP & CTO Zohar Loshitzer, President
Promedica
Shannon Stoddard, President
pSivida
Paul Ashton, CEO Quantel Medical
Peter Falzon, Business Development
Rainbow Medical
Roy Katz, VP Business Development
Refocus Group Mike Judy, CEO
Stephon C. Payseur, Director Strategic Communications
Regeneron
Keith Baker, Associate Director of Medical Affairs, Ophthalmology Abby Cahn, Sr. Manager Strategic Accounts Planning
Nouhad Husseini, Senior Director
Husain Kazmi, Director Clinical Sciences, Ophthalmology Neil Levine, Sr. Director of Marketing
John Magliocchetti, Sr. Director Ophthalmology, New Products Marketing Carl Romano, Executive Director, Ophthalmology
Namrata Saroj, Sr. Medical Director Medical Affairs, Ophthalmology
Replenish Ted Danse, CEO
Retina Associates Ben Z. Cohen, Physician
Retina Consultants
Charles Vygantas, MD, Physician
Retina Consultants of Delmarva Jeffrey Benner
Retina Health Center
Alexander Eaton, MD, Physician
Retina-Vitreous Associates David Boyer, MD
Steven Cohen, MD, Partner Firas M. Rahhal, MD, Partner
RetinaNet
Mark Nelson, MD, MBA, CEO RetroSense Therapeutics Sean Ainsworth, CEO
ReVision Optics
Luis Vargas, MD, VP, Medical Affairs & Medical Director
Rocky Mountain Ophthalmology Kevin Cuevas, Cornea Specialist
Rohto pharmaceutical
Takahiro Kurose, Business development
Rowen Laser Vision Center Sheri Rowen, Medical Director
Rutgers-New Jersey Medical School
Marco Zarbin, MD, Professor & Chair, Institute of Ophthalmology & Visual Science
RxGen
Christopher Stanley, VP & CBO
RXi Pharmaceuticals Corporation Geert Cauwenbergh, President & CEO
SalutarisMD
Maryline Boulay, Corporate Development & EU Affairs Laurence Marsteller, MD, CEO
Sandbox Strategic
Amy Jacobs, Vice President
Dawn Thompson, President & Co-Founder
Santen
Yusuf Ali, VP, R & D Masato Asai, Head Robert Bauer, Manager
Harumi Kawabata, Licensing Coordinator Jerome Martinez, President
Sri Mudumba, Sr. Director, Pharmaceutical Dev.
Takashi Noaki, Scientific Affairs & Global Business Development Ken Shimokawa, Senior Manager
Tatsuyuki Yamane, Senior Manager, Global BD Scheie Eye Institute/University of Pennsylvania Alexander Brucker, MD, Professor of Ophthalmology
Second Sight Medical Products
Robert Greenberg, MD, PhD, President & CEO
See Clearly Vision Group Dr. Rajesh Rajpal, Physician
Sensimed AG David Bailey, CEO
Sentinel Diagnostic Imaging David Meadows, CEO
Sharklet Technologies Mark Spiecker, CEO
Shifamed
Mariam Maghribi, Chief Business Officer
Shire
Robert Dempsey, Vice President & Business Unit Head Kathryn Gregory, Sr. Director Business Development Reza Haque, MD, Vice President, Ophthalmology Scott Hunter, US Marketing Lead - Ophthalmology Gregory Robinson, Senior Director, Scientific Licensing Monica Roy, Director, Clinical Development, Ophthalmology
SightLife
Monty Montoya, President & CEO
SightLine Partners
Buzz Benson, Managing Director Joe Biller, Managing Director
Sightpath Medical
Joel Gaslin, VP of Sales & Marketing
Signet Healthcare Partners Joyce Erony, Managing Director
Silicon Valley Bank
Hans Hinrichs, Managing Director Brett Maver, Director
Singapore Eye Research Institute
Dr. Danny Belkin, Business Development Director Xiaoqin Fang, Technology Development Manager
Slack
Samantha Costa, Online Managing Editor David Mullin, Editor-in-Chief
Joan-Marie Stiglich, Chief Content Officer
South Florida Vision Associates Jennifer Loh, Physician
Square 1 Partners
Lauren Kanner, Co-Founder & Strategist
Stanford University
Mark Blumenkranz, MD, Professor & Chairman, Department of Ophthalmology Suzann Pershing, MD, Chief, Ophthalmology & VA Palo Alto Health Care System Kuldev Singh, MD, Professor
Stem Cells
Joel Naor, VP, Clinical Development, Ophthalmology
Strategic Intelligence Babak Nemati, President
Strategic Pharma Solutions Courtney Kaprelian, COO
Stroma Medical Corporation Douglas Daniels, CEO
Summit Eye Associates William Gates, Physician
Surgilum/Surgical Eye Care Alan Brown, MD, President
SurgiVision Consultants
Guy M. Kezirian, MD, President
SV Life Sciences Advisers
Jim Watchtman, Venture Partner SVB Capital
Jonathan Norris, Managing Director
SVLSA
Steven Straus, None
Taejoon Pharm Joon Youb, PhD
TearScience
Nicole Wicker, CFO
TearScience
Tim Willis, President & CEO
Technolas
Kristian Hohla, CEO
Teva Pharmaceuticals
Jeanne Andronowitz, Global Marketing Director Christine Foster, VP, Search & Evaluation
Diane Harvey, Senior Director, Search & Evaluation
Texas Retina Associates Karl Csaky, MD, PhD, Partner
The Center for Eye Care & Optical
James F. Collins, MD, Founder & Medical Director
The Foundry
Hanson Gifford, Partner
The Fundingsland Group
Bradley Fundingsland, President Erin Schalhorn, Vice President
The Magnum Group
Randy McDonald, Managing Director & President
The New York Eye & Ear Infirmary
Robert Ritch, MD, Surgeon Director & Chief, Glaucoma Services The Retina Clinic
Kartik Patel, Physician
Theravance Biopharma
Jeff Finer, VP Research, Molecular & Cellular Biology
Thomas Resource Group Terry Thoma
ThromboGenics
Laurens Bouckaert, Global Marketing Director Jean Feyen, PhD, Head Preclinical Research Pascal Merchiers, Head Project Development
David Pearson, Global Head, Corporate Development
Topcon
Michael Sinai, Senior Manager, Product Planning
Transcend Medical
Ginger Clasby, VP, Clinical & Regulatory Affairs Brian Walsh, CEO
Translatum Medicus inc (TMi) Shelley Boyd, President & CSO
Trial Runners Patrick Healy, CEO
TrueVision Systems
Mark Maire, Vice President of Sales
Burton Tripathi, CTO & EVP of Product Development & Operations
Tufts Medical Center
Daniela Ferrara, MD, PhD, Assistant Professor of Ophthalmology
UCLA School of Medicine
David Sarraf, MD, Clinical Professor, Ophthalmology
UCSF
Daniel Schwartz, MD
United Scientific Associates Dr. Hakam Ghabra
University of California San Diego
Robert Weinreb, MD, Chairman & Distinguished Professor
University of California SF
Stephen McLeod, MD, Professor & Chairman
University of California, Irvine
Roger Steinert, MD, Professor & Chair
University of Florida
William Hauswirth, PhD, Rybaczki-Bullard Professor of Ophthalmology Nick Muzyczka, Dept of Molecular Genetics & Microbiology
University of Illinois at Chicago
Dimitri Azar, Dean of College of Medicine William Mieler, MD, Professor & Vice-Chairman Suseelan Pookote, Senior Technology Manager
University of Rochester
Prof. Wayne H. Knox, Professor Optics & Visual Science
Scott MacRae, MD, Director of Refractive Surgery, Professor of Visual Science
University of Southern California Mark Humayun, MD, PhD, Professor
University of Sydney
Michael Lawless, Clinical Associate Professor
Unilife
Gautam Shetty, Director & General Manager
USC
Rohit Varma, Professor & Chair
Valeant - Bausch & Lomb Division
Baldo Scassellati Sforzolini, VP, Development Eye Care
Valley Retina Institute
Dr. Victor Gonzalez, Physician & Founder
Vance Thompson Vision
Vance Thompson, MD, Director of Refractive Surgery
VCU, Richmond/INOVA Fairfax Hospital Michael Ross, MD, Professor
Versant Ventures
Andy Corley, Venture Partner
William J. Link, PhD, Managing Director Charles Warden, Managing Director
Vestrum Health
Nadeem Ahmad, Director of Operations Nicholas Anderson, Co-Founder
Tom Brogan, CEO
John Pollack, Co-Founder David Williams, Co-Founder
VisionCare Ophthalmic Technologies Allen Hill, CEO
Vision Medicines
Brinda Balakrishnan, MD, PhD, Senior Director Product Development & Strategy Jonae Barnes, SVP, Investor Relations & Corporate Communications
Robert Kim, Vice President Research & Development Chris Varma, CEO
VisuMedics
George Marcellino, Vice President
Vitreous Retina Macula Consultants of New York Bailey Freund, MD
Vittamed Corporation Remis Bistras, CEO
VRMNJ
Vatsal Doshi, Physician
WaveTec Vision Systems
Craig Bender, Chief Operating Officer Michael Breen, VP, Clinical
Scott Cooper, CFO Thomas Frinzi, CEO
Whipps Cross University Hospital Marwan Ghabra
Williams Eye Surgery
Johnny Williams, MD, Physician
Wills Eye Institute
Julia Haller, MD, Ophthalmologist-in-Chief
Wilmer Eye Institute
Howard Ying, Associate Professor of Ophthalmology
WilmerHale
Brian Johnson, Partner
Windham Ventures Cynthia Yee, Principal
Woodhams Eye Clinic George Waring, III, Physician
Xcovery Vision
Teri Ardleigh Swift, Co-Founder & VP Business Development
XOMA
Oscar Cuzzani, VP, Clinical Science
Tom Klein, VP & Chief Commercial Officer Brion Raymond, Sr. Director, Marketing Paul Rubin, Chief Medical Officer John Varian, CEO
Ziemer Ophthalmic Systems AG Sandro Palumbo, VP Marketing
Independent Keith Barton, MD Scott Beardsley Andre Curi
William De La Pena, MD
Donald Fishbein, Healthcare Executive Masayuki Kobayashi
Dr. Bruce M. Lennox, Physician Julie Lyons
Marion Munk
Michael Nissen, MD, Physician Andrew Schachat
Susan Schneider
Arunan Sivalingam, MD Todd Smith
